We are on our way to three approved vaccines for use against the coronavirus in the U.S. as an FDA panel meets on emergency-use approval today. The White House is planning to allocate between 3 million and 4 million of Johnson and Johnson's vaccine doses next week pending that authorization. To discuss, we were joined by Dr. Richard Besser, President and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC.